Novo-Nordisk A/S (NVO) is a publicly traded Healthcare sector company. As of May 20, 2026, NVO trades at $44.95 with a market cap of $196.24B and a P/E ratio of 0.00. NVO moved +1.77% today. Year to date, NVO is -18.22%; over the trailing twelve months it is -33.91%. Its 52-week range spans $35.12 to $121.34. Analyst consensus is neutral with an average price target of $43.00. Rallies surfaces NVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes NVO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $44.95 |
| Market Cap | $196.24B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 1.22% |
| 52-Week High | $121.34 |
| 52-Week Low | $35.12 |
| Volume | 9.29M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
8 analysts cover NVO: 0 strong buy, 1 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $43.00.